HHS & VA Announce Bold, Comprehensive Partnership to Advance Rapid-Acting Mental Health Treatments for Veterans
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
July 13, 2026
Clinical Report: HHS and VA Forge Comprehensive Partnership for Veterans' Mental Health
Overview
The U.S. Department of Health and Human Services (HHS) and the Department of Veterans Affairs (VA) have signed a Memorandum of Understanding to enhance collaboration on rapid-acting mental health treatments for veterans. This partnership focuses on research, clinical development, and the deployment of FDA-approved psychedelic drug products for serious mental health conditions.
Background
The mental health of veterans is a critical public health issue, with many suffering from serious conditions such as PTSD and depression. The collaboration between HHS and VA is designed to streamline the transition of these treatments from research to clinical practice.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
- The MOU between HHS and VA aims to enhance research and clinical development of rapid-acting psychedelic treatments for veterans.
- Efforts will include increasing clinical trial participation and training healthcare providers in administering these treatments.
- Real-world data will be collected to evaluate the safety and effectiveness of future FDA-approved treatments.
- The agreement is part of a broader initiative under President Trump’s Executive Order 14401 to accelerate medical treatments for serious mental illness.
- The FDA is also collaborating with the VA to advance the development of innovative therapies for serious mental illnesses.
Clinical Implications
The partnership focuses on workforce training, evidence-based clinical protocols, and data sharing to prepare the VA healthcare system for future FDA-approved treatments.
Conclusion
The collaboration between HHS and VA represents a step towards integrating rapid-acting mental health treatments into veteran care.
Related Resources & Content
- U.S. Department of Health and Human Services, Press Release, 2026 -- HHS and VA Forge Comprehensive Partnership to Enhance Rapid-Acting Mental Health Treatments for Veterans
- Management of Posttraumatic Stress Disorder and Acute Stress Disorder 2023 - VA/DOD Clinical Practice Guidelines
- Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis | Anesthesiology | JAMA Psychiatry | JAMA Network
- The ASCO Post — NCI and VA Launch NAVIGATE to Boost Veterans’ Access to Cancer Clinical Trials
- BMJ Mental Health — Predictive analytics to direct clinical attention to complex patients with elevated suicide risk: enhancement of the Veterans Health Administration REACH VET model
- Frontiers in Digital Health — Understanding the value of virtual care technologies: development of a framework in the veterans health administration
- NCI and VA Launch NAVIGATE to Boost Veterans’ Access to Cancer Clinical Trials
- Predictive analytics to direct clinical attention to complex patients with elevated suicide risk: enhancement of the Veterans Health Administration REACH VET model
- Understanding the value of virtual care technologies: development of a framework in the veterans health administration
- Management of Posttraumatic Stress Disorder and Acute Stress Disorder 2023 - VA/DOD Clinical Practice Guidelines
- Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis | Anesthesiology | JAMA Psychiatry | JAMA Network
- Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial | Complementary and Alternative Medicine | JAMA Network Open | JAMA Network
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
